SecBot SecBot
Insider Cluster (5 insiders) ·Filed Jun 26, 2026

IMVT

Immunovant, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago
Insider cluster: 5 insiders, $2.8M total
Actionable Insight • Neutral

This insider cluster is routine and lacks materiality. No bearish signal — the sales are small relative to market cap and coincide with option exercises. Monitor upcoming pipeline catalysts (e.g., IMVT-1402 data) for true directional moves.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
IMVT ▼ -3.17% at T+60d
NEUTRAL call -3.17% · α vs SPY -7.55% · entry $38.51 → $37.29
Entry = T+0 close
Jun 26, 2026
via day close
T+1d
+0.05%
call +0.05% · α -0.73%
$38.53
settled 4mo ago
T+5d
+0.23%
call +0.23% · α -1.15%
$38.60
settled 4mo ago
T+20d
+2.34%
call +2.34% · α +2.62%
$39.41
settled 3mo ago
T+60d
-3.17%
call -3.17% · α -7.55%
$37.29
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Five Immunovant insiders (CFO, COO, CTO, CLO, and a director) sold a combined $2.85M in open-market shares on June 26, 2026, all at ~$38.18. The total represents just 0.036% of the $7.9B market cap — a trivial amount. The sales coincide with option exercises and are likely routine tax-related or liquidity-driven transactions, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$2.9M
Insiders
5

Key Facts

  • 5 insiders sold shares on June 26, 2026, totaling $2.85M
  • Sales were 0.036% of Immunovant's $7.9B market cap
  • All sales occurred at ~$38.18 per share
  • Multiple insiders also exercised stock options on the same day (non-cash events)
  • CTO Jay Stout sold the largest block: $1.27M (33,277 shares)

Financial Impact

Insider sales of $2.85M represent 0.036% of market cap — immaterial

dilution

Risk Factors

  • No material risk from this filing; insider selling is minimal and likely liquidity-driven

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
75% bullish (24 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IMVT-1782517656485
12 reports for IMVT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for IMVT — sortable, filterable
TypeNow
Aug 6, 2026
11w ago
8-K
BEARISH ★ 6/10
$39.74 $39.12▲ +1.56%▲ +2.16%$27.68 (+30.35%)
Jul 24, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$40.09 $43.32▲ +8.06%▲ +4.76%$27.68 (−30.96%)
Jun 26, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
144
NEUTRAL ★ 2/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
144
NEUTRAL ★ 4/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 15, 2026
18w ago
144
NEUTRAL ★ 2/10
$33.61 $38.77▲ +15.35%▲ +15.15%$27.68 (−17.64%)
May 28, 2026
21w ago
144
NEUTRAL ★ 3/10
$33.30 $38.51▲ +15.65%▲ +17.44%$27.68 (−16.88%)
May 20, 2026
22w ago
8-K
MIXED ★ 6/10
$35.56 $35.34▼ −0.62%▼ −1.36%$27.68 (−22.16%)
May 20, 2026
22w ago
Press Release
BULLISH ★ 7/10
$35.56 $35.34▼ −0.62%▼ −1.36%$27.68 (−22.16%)
Showing 10 of 12

US Market Status

Market Open — Closes in 5h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 26, 2026